STATEMENT OF USE - TO EXAMINER
to examiner
on 02 Aug 2024
Last Applicant/ Owned by
Dag Hammarskjölds väg 54B
Uppsala
SE
SE-75237
Serial Number
97384814 filed on 27th Apr 2022
Registration Number
N/A
Correspondent Address
Mark H. Tidman
Mark H. Tidman BAKER & HOSTETLER LLP
Washington Square, Suite 1100
Washington, DC 20036-5304
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
BIOVICA
(Based on 44(e)) Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparation Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
(Based on 44(e)) Medical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
(Based on 44(e)) Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic activity; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of enzymatic activity
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
(Based on 44(e)) Diagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
(Based on Use in Commerce) Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use
First Use Date in General
24th Mar 2023
First Use Date in Commerce
24th Mar 2023
Mark Details
Serial Number
No 97384814
Mark Type
No Service Mark
Attorney Docket Number
No 47727.020086
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Aug 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 03rd Jul 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 03rd Jul 2024 | TEAS STATEMENT OF USE RECEIVED |
| 03rd Jul 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 03rd Jul 2024 | USE AMENDMENT FILED |
| 21st Feb 2024 | TEAS DELETE 1(B) BASIS RECEIVED |
| 09th Jan 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 14th Nov 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 14th Nov 2023 | PUBLISHED FOR OPPOSITION |
| 25th Oct 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |